my view if it matters is that the original patented libraries were based on genetically diverse organisms blah blah that were highly stable etc due to evolution, but it would appear may not neccesarily have been that good at penetrating human cells which was the whole point. The major breakthrough now it appears is we have patented a library that includes peptides derived from virus or viral materials, which already have obvious and proven abiliy to penetrate human cells. To me it seems any major descovery should be more likely using phylomers derived from these types of cells as they have known cell penetrating ability. All the questions on the original phylomer library seem to be around cell penetration ability with or without payload, and around theyre effective half life while in contact with human blood etc. Surely to have a patent on phylomees derived from viral factors is a najor step for the libraries, but would be a lot more use if we had 20 mil in the bank.
Re the SP could this be the final test of 2.5 c as resistance now before the next massive dump?
- Forums
- ASX - By Stock
- Ann: Core patent granted in Australia
PYC
pyc therapeutics limited
Add to My Watchlist
3.03%
!
$1.28

my view if it matters is that the original patented libraries...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | $1.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 40248 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.275 |
1 | 13987 | 1.265 |
2 | 16060 | 1.260 |
1 | 12000 | 1.255 |
2 | 2800 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 40248 | 3 |
1.330 | 5000 | 1 |
1.345 | 53113 | 2 |
1.350 | 22000 | 2 |
1.360 | 5958 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online